Status:
WITHDRAWN
Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Conditions:
Breast Cancer
Eligibility:
FEMALE
25+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate whether high-resolution magnetic resonance imaging of the axilla with spectroscopy can identify nodal features suggestive of metastatic involvement in patients...
Detailed Description
Breast cancer is the second leading cause of death in women. The spread of cancer from the breast to the lymph nodes is a significant factor in determining breast cancer survival. Currently, surgical ...
Eligibility Criteria
Inclusion
- Patients diagnosed with recent (within 60 days) invasive breast cancer.
- No previous ipsilateral axillary surgery.
Exclusion
- Patients diagnosed with in situ disease.
- Patients with previous ipsilateral axillary surgery.
- Patients with MRI/MRA contraindications such as a cardiac pacemaker, an aneurysm clip, cochlear implants, and metal in the eyes.
- Patients who have had a moderate or severe contrast reaction to intravenous gadolinium-DTPA.
- Patients who are clinically not stable.
- Patients who cannot give consent.
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00312637
Start Date
March 1 2005
End Date
March 1 2008
Last Update
May 1 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mammography Clinic - UNC Hospitals
Chapel Hill, North Carolina, United States, 27514